i2020 Accelerator Launches Two Oncology Startups

San Diego-based i2020 Acclerator, a startup accelerator company which is backed by Torrey Pines Investment, announced this morning that it has launched two new startups. The company said that it has launched Gwynant Therapeutics and Celyn Therapeutics, both of which will focus on oncology, bringing proprietary small molecule products to the clinic targeting cancer. The size of the investment in the two companies was not announced, however, the accelerator program says that so far it has provide funding for 9 companies, worth over $68.5M. As part of the funding, Carl Gordon and Iain Dukes from OrbiMed, Nikolay Savchuk from Torrey Pines Investment and Augustine Lawlor from Health Care Ventures have joined the board of directors of both Gwynant and Celyn Therapeutics.